Clinical outcomes of combined versus separate carbachol and brimonidine drops in correcting presbyopia

BACKGROUND: To test and compare in a masked fashion the efficacy of using a parasympathomimetic drug (3% carbachol) and an alpha-2 agonist (0.2% brimonidine) in both combined and separate forms to create optically beneficial miosis to pharmacologically improve vision in presbyopia. METHODS: A prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelkader, Almamoun, Kaufman, Herbert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139101/
https://www.ncbi.nlm.nih.gov/pubmed/27981057
http://dx.doi.org/10.1186/s40662-016-0065-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139101/
https://www.ncbi.nlm.nih.gov/pubmed/27981057
http://dx.doi.org/10.1186/s40662-016-0065-3

Ejemplares similares